333 related articles for article (PubMed ID: 33808714)
1. Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.
Mitchell SD; Sidiropoulos C
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808714
[TBL] [Abstract][Full Text] [Related]
2. Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.
Jost WH
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33503872
[TBL] [Abstract][Full Text] [Related]
3. Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea.
Hosp C; Naumann MK; Hamm H
Semin Neurol; 2016 Feb; 36(1):20-8. PubMed ID: 26866492
[TBL] [Abstract][Full Text] [Related]
4. [Management of autonomic dysfunction in Parkinson's disease].
Crespo-Burillo JA; Alarcia-Alejos R
Rev Neurol; 2015 Apr; 60(8):355-64. PubMed ID: 25857860
[TBL] [Abstract][Full Text] [Related]
5. Use of botulinum toxin in Parkinson's disease.
Jocson A; Lew M
Parkinsonism Relat Disord; 2019 Feb; 59():57-64. PubMed ID: 30579818
[TBL] [Abstract][Full Text] [Related]
6. An update on the use of botulinum toxin therapy in Parkinson's disease.
Mills R; Bahroo L; Pagan F
Curr Neurol Neurosci Rep; 2015 Jan; 15(1):511. PubMed ID: 25407133
[TBL] [Abstract][Full Text] [Related]
7. Non-motor symptoms in Parkinson's disease.
Park A; Stacy M
J Neurol; 2009 Aug; 256 Suppl 3():293-8. PubMed ID: 19711119
[TBL] [Abstract][Full Text] [Related]
8. [Disorders of autonomic regulation in Parkinson syndrome].
Jost WH
Fortschr Neurol Psychiatr; 1995 May; 63(5):194-205. PubMed ID: 7782020
[TBL] [Abstract][Full Text] [Related]
9. Managing autonomic dysfunction in Parkinson's disease: a review of emerging drugs.
Kulshreshtha D; Ganguly J; Jog M
Expert Opin Emerg Drugs; 2020 Mar; 25(1):37-47. PubMed ID: 32067502
[No Abstract] [Full Text] [Related]
10. Sialorrhea in Parkinson's Disease.
Isaacson J; Patel S; Torres-Yaghi Y; Pagán F
Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33142833
[TBL] [Abstract][Full Text] [Related]
11. Disease-oriented approach to botulinum toxin use.
Jankovic J
Toxicon; 2009 Oct; 54(5):614-23. PubMed ID: 19073203
[TBL] [Abstract][Full Text] [Related]
12. Botulinum Toxin Therapy for Nonmotor Aspects of Parkinson's Disease.
Sławek J; Madaliński M
Int Rev Neurobiol; 2017; 134():1111-1142. PubMed ID: 28805566
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
[No Abstract] [Full Text] [Related]
14. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
Sheffield JK; Jankovic J
Expert Rev Neurother; 2007 Jun; 7(6):637-47. PubMed ID: 17563247
[TBL] [Abstract][Full Text] [Related]
15. Recognition and treatment of autonomic disturbances in Parkinson's disease.
Li K; Reichmann H; Ziemssen T
Expert Rev Neurother; 2015 Oct; 15(10):1189-203. PubMed ID: 26416396
[TBL] [Abstract][Full Text] [Related]
16. From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction.
Rempel L; Malik RN; Shackleton C; Calderón-Juárez M; Sachdeva R; Krassioukov AV
Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393175
[TBL] [Abstract][Full Text] [Related]
17. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.
Egevad G; Petkova VY; Vilholm OJ
J Parkinsons Dis; 2014; 4(3):321-6. PubMed ID: 24919823
[TBL] [Abstract][Full Text] [Related]
18. Botulinum Toxin Therapy for Parkinson's Disease.
Wagle Shukla A; Malaty IA
Semin Neurol; 2017 Apr; 37(2):193-204. PubMed ID: 28511260
[TBL] [Abstract][Full Text] [Related]
19. State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease.
Quarracino C; Otero-Losada M; Capani F; Pérez-Lloret S
Expert Opin Pharmacother; 2020 Mar; 21(4):445-457. PubMed ID: 31957505
[No Abstract] [Full Text] [Related]
20. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
Seppi K; Weintraub D; Coelho M; Perez-Lloret S; Fox SH; Katzenschlager R; Hametner EM; Poewe W; Rascol O; Goetz CG; Sampaio C
Mov Disord; 2011 Oct; 26 Suppl 3(0 3):S42-80. PubMed ID: 22021174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
